Europace business division for ABS investors has been shut down as previously announced

--------------------------------------------------------------------------------
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
the content of this announcement.
--------------------------------------------------------------------------------

banks/companies/finances/stock market

Berlin (euro adhoc) - 6 March 2009: The sale of the responsible
subsidiary company marks the successful closure of Hypoport AG's
Europace business division for ABS investors. Following the sale, all
of the business divisions that now comprise Hypoport Group are
profitable. The Group's focus on core competencies and highly
profitable business divisions aims to secure sustained growth, both
now and in the future.

The subsidiary company that was responsible for business operations
with ABS investors has been sold to an investment company based in
North Germany. This marks the conclusion with effect from 1 January
2009 of Hypoport's intention to shut down its loss-making "Europace
for ABS investors" business division, which was announced back in
October of last year. As such, the company will no longer be included
in Hypoport Group's scope of consolidation from 2009 onwards and will
therefore cease to burden the Group's results in the future. The
profitable business with ABS issuers, which is located in Amsterdam,
is not affected by the closure; it will continue to operate normally
and grow.

Hypoport therefore started fiscal year 2009 with a solid structure
and business divisions that are, without exception, profitable. As
Ronald Slabke, Co-CEO at Hypoport, explains: "Bundling our resources
to concentrate on our core competencies is the only means to ensure
that we can develop and secure the standards demanded of our
successful business models". These capacities can now be put to
better and sustained use, not only for the consistently increasing
numbers of producers and sales organisations that are connected to
the established Europace platform, but also for growing the Genopace
and Starpool joint ventures. Slabke continues: "The positive overall
outcome of the 13th Europace Conference, which took place on 2 and 3
March 2009, confirmed the enormous growth potential that is still
offered by these pillars of our business".

The all-round financial services provided by Hypoport subsidiary Dr.
Klein & Co. AG are also in a superb position to tackle the new fiscal
year. The wide range of services offered by this second central
pillar of the Group's business operations is firmly anchored in the
marketplace. The sales channels used for agency services by Dr. Klein
include face-to-face, telephone and online consulting, allowing the
company to reach its clients where they are based.

Stephan Gawarecki, member of Dr. Klein's Management Board, explains
the growing advantages offered by this business model in the
marketplace: "Impartiality, competence, transparency, product
diversity and customer proximity will all play a crucial role in
mediating financial services in the future. And these are precisely
the strengths that Dr. Klein has been demonstrating for years now".

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Hypoport AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Michaela Reimann

Group Communications Manager

Hypoport AG

Klosterstraße 71

D-10179 Berlin

Mobile: +49 (0) 151 / 58 04 - 1936

Tel.: +49 (0) 30 / 4 20 86 - 1936

Fax: +49 (0) 30 / 4 20 86 - 1999

E-Mail: michaela.reimann@hypoport.de

Internet: www.hypoport.de

Branche: Financial & Business Services
ISIN: DE0005493365
WKN: 549336
Börsen: Börse Frankfurt / regulated dealing/prime standard